Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Plos One
|
January 23, 2016
Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey
Chern-En Chiang, Lisa Naditch-Brûlé, Sandrine Brette, et al.
Archives of Cardiovascular Diseases
|
December 6, 2008
What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure?
Eloi Marijon, Bernard Iung, Ana-Olga Mocumbi, et al.
Genetic Testing and Molecular Biomarkers
|
March 26, 2011
The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients
Tahar Chakroun, Faouzi Addad, Saloua Yacoub, et al.
Prostaglandins & Other Lipid Mediators
|
August 10, 2017
Identification of long and very long chain fatty acids, plasmalogen-C16:0 and phytanic acid as new lipid biomarkers in Tunisian coronary artery disease patients
Samia Hadj Ahmed, Nadia Koubaa, Wafa Kharroubi, et al.
Journal of Thrombosis and Thrombolysis
|
April 22, 2009
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease
Faouzi Addad, Tahar Chakroun, Fatma Abderazek, et al.
International Journal of Cardiology
|
October 16, 2003
Eighteen-year experience with echinococcosus of the heart: clinical and echocardiographic features in 14 patients
Khaldoun Ben-Hamda, Faouzi Maatouk, Mohamed Ben-Farhat, et al.
Thrombosis Research
|
June 8, 2007
Screening for aspirin resistance in stable coronary artery patients by three different tests
Tahar Chakroun, Faouzi Addad, Fatma Abderazek, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 27, 2010
Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease
Faouzi Addad, Ismail Elalamy, Tahar Chakroun, et al.
Kidney International
|
November 7, 2022
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease
Johannes F E Mann, Philip Joseph, Peggy Gao, et al.
Lipids in Health and Disease
|
March 17, 2018
Correlation of trans fatty acids with the severity of coronary artery disease lesions
Samia Hadj Ahmed, Wafa Kharroubi, Nadia Kaoubaa, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Plos One
|
January 23, 2016
Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey
Chern-En Chiang, Lisa Naditch-Brûlé, Sandrine Brette, et al.
Archives of Cardiovascular Diseases
|
December 6, 2008
What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure?
Eloi Marijon, Bernard Iung, Ana-Olga Mocumbi, et al.
Genetic Testing and Molecular Biomarkers
|
March 26, 2011
The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients
Tahar Chakroun, Faouzi Addad, Saloua Yacoub, et al.
Prostaglandins & Other Lipid Mediators
|
August 10, 2017
Identification of long and very long chain fatty acids, plasmalogen-C16:0 and phytanic acid as new lipid biomarkers in Tunisian coronary artery disease patients
Samia Hadj Ahmed, Nadia Koubaa, Wafa Kharroubi, et al.
Journal of Thrombosis and Thrombolysis
|
April 22, 2009
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease
Faouzi Addad, Tahar Chakroun, Fatma Abderazek, et al.
International Journal of Cardiology
|
October 16, 2003
Eighteen-year experience with echinococcosus of the heart: clinical and echocardiographic features in 14 patients
Khaldoun Ben-Hamda, Faouzi Maatouk, Mohamed Ben-Farhat, et al.
Thrombosis Research
|
June 8, 2007
Screening for aspirin resistance in stable coronary artery patients by three different tests
Tahar Chakroun, Faouzi Addad, Fatma Abderazek, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 27, 2010
Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease
Faouzi Addad, Ismail Elalamy, Tahar Chakroun, et al.
Kidney International
|
November 7, 2022
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease
Johannes F E Mann, Philip Joseph, Peggy Gao, et al.
Lipids in Health and Disease
|
March 17, 2018
Correlation of trans fatty acids with the severity of coronary artery disease lesions
Samia Hadj Ahmed, Wafa Kharroubi, Nadia Kaoubaa, et al.
Page
of 11